1
|
Siegel R, Ma J, Zou Z and Jemal A: Cancer
statistics, 2014. CA Cancer J Clin. 64:9–29. 2014. View Article : Google Scholar : PubMed/NCBI
|
2
|
Su Z, Yang Z, Xu Y, Chen Y and Yu Q:
MicroRNAs in apoptosis, autophagy and necroptosis. Oncotarget.
6:8474–8490. 2015. View Article : Google Scholar : PubMed/NCBI
|
3
|
Liu L, Qiu M, Tan G, Liang Z, Qin Y, Chen
L, Chen H and Liu J: miR-200c inhibits invasion, migration and
proliferation of bladder cancer cells through down-regulation of
BMI-1 and E2F3. J Transl Med. 12:3052014. View Article : Google Scholar : PubMed/NCBI
|
4
|
Luo Q, Li X, Gao Y, Long Y, Chen L, Huang
Y and Fang L: MiRNA-497 regulates cell growth and invasion by
targeting cyclin E1 in breast cancer. Cancer Cell Int. 13:952013.
View Article : Google Scholar : PubMed/NCBI
|
5
|
Wang W, Ren F, Wu Q, Jiang D, Li H and Shi
H: MicroRNA-497 suppresses angiogenesis by targeting vascular
endothelial growth factor A through the PI3K/AKT and MAPK/ERK
pathways in ovarian cancer. Oncol Rep. 32:2127–2133.
2014.PubMed/NCBI
|
6
|
Li W, Jin X, Deng X, Zhang G, Zhang B and
Ma L: The putative tumor suppressor microRNA-497 modulates gastric
cancer cell proliferation and invasion by repressing eIF4E. Biochem
Biophys Res Commun. 449:235–240. 2014. View Article : Google Scholar : PubMed/NCBI
|
7
|
Itesako T, Seki N, Yoshino H, Chiyomaru T,
Yamasaki T, Hidaka H, Yonezawa T, Nohata N, Kinoshita T, Nakagawa
M, et al: The microRNA expression signature of bladder cancer by
deep sequencing: The functional significance of the miR-195/497
cluster. PLoS One. 9:e843112014. View Article : Google Scholar : PubMed/NCBI
|
8
|
Vimala K, Sundarraj S, Sujitha MV and
Kannan S: Curtailing overexpression of E2F3 in breast cancer using
siRNA (E2F3)-based gene silencing. Arch Med Res. 43:415–422. 2012.
View Article : Google Scholar : PubMed/NCBI
|
9
|
Hurst CD, Tomlinson DC, Williams SV, Platt
FM and Knowles MA: Inactivation of the Rb pathway and
overexpression of both isoforms of E2F3 are obligate events in
bladder tumours with 6p22 amplification. Oncogene. 27:2716–2727.
2008. View Article : Google Scholar :
|
10
|
Olsson AY, Feber A, Edwards S, Te Poele R,
Giddings I, Merson S and Cooper CS: Role of E2F3 expression in
modulating cellular proliferation rate in human bladder and
prostate cancer cells. Oncogene. 26:1028–1037. 2007. View Article : Google Scholar
|
11
|
Shen H, Morrison CD, Zhang J, Underwood W
III, Yang N, Frangou C, Eng K, Head K, Bollag RJ, Kavuri SK, et al:
6p22.3 amplification as a biomarker and potential therapeutic
target of advanced stage bladder cancer. Oncotarget. 4:2124–2134.
2013. View Article : Google Scholar : PubMed/NCBI
|
12
|
Huang L, Luo J, Cai Q, Pan Q, Zeng H, Guo
Z, Dong W, Huang J and Lin T: MicroRNA-125b suppresses the
development of bladder cancer by targeting E2F3. Int J Cancer.
128:1758–1769. 2011. View Article : Google Scholar
|
13
|
Oeggerli M, Tomovska S, Schraml P,
Calvano-Forte D, Schafroth S, Simon R, Gasser T, Mihatsch MJ and
Sauter G: E2F3 amplification and overexpression is associated with
invasive tumor growth and rapid tumor cell proliferation in urinary
bladder cancer. Oncogene. 23:5616–5623. 2004. View Article : Google Scholar : PubMed/NCBI
|
14
|
Welch C, Chen Y and Stallings RL:
MicroRNA-34a functions as a potential tumor suppressor by inducing
apoptosis in neuroblastoma cells. Oncogene. 26:5017–5022. 2007.
View Article : Google Scholar : PubMed/NCBI
|
15
|
Sylvestre Y, De Guire V, Querido E,
Mukhopadhyay UK, Bourdeau V, Major F, Ferbeyre G and Chartrand P:
An E2F/miR-20a autoregulatory feedback loop. J Biol Chem.
282:2135–2143. 2007. View Article : Google Scholar
|
16
|
Su J, Wang Q, Liu Y and Zhong M: miR-217
inhibits invasion of hepatocellular carcinoma cells through direct
suppression of E2F3. Mol Cell Biochem. 392:289–296. 2014.
View Article : Google Scholar : PubMed/NCBI
|
17
|
Xu Y, Zhao F, Wang Z, Song Y, Luo Y, Zhang
X, Jiang L, Sun Z, Miao Z and Xu H: MicroRNA-335 acts as a
metastasis suppressor in gastric cancer by targeting Bcl-w and
specificity protein 1. Oncogene. 31:1398–1407. 2012. View Article : Google Scholar :
|
18
|
Iseki H, Takagi M, Kuroda Y, Katsuda K,
Mikami O, Tsunemitsu H and Yamakawa M: Application of a
SYBR®Green one step real-time RT-PCR assay to detect
type 1 porcine reproductive and respiratory syndrome virus. J Vet
Med Sci. 76:1411–1413. 2014. View Article : Google Scholar : PubMed/NCBI
|
19
|
Xu J, Wang T, Cao Z, Huang H, Li J, Liu W,
Liu S, You L, Zhou L, Zhang T, et al: MiR-497 downregulation
contributes to the malignancy of pancreatic cancer and associates
with a poor prognosis. Oncotarget. 5:6983–6993. 2014. View Article : Google Scholar : PubMed/NCBI
|
20
|
Zhao WY, Wang Y, An ZJ, Shi CG, Zhu GA,
Wang B, Lu MY, Pan CK and Chen P: Downregulation of miR-497
promotes tumor growth and angiogenesis by targeting HDGF in
non-small cell lung cancer. Biochem Biophys Res Commun.
435:466–471. 2013. View Article : Google Scholar : PubMed/NCBI
|
21
|
Wang L, Li B, Li L and Wang T:
MicroRNA-497 suppresses proliferation and induces apoptosis in
prostate cancer cells. Asian Pac J Cancer Prev. 14:3499–3502. 2013.
View Article : Google Scholar : PubMed/NCBI
|
22
|
Shen L, Li J, Xu L, Ma J, Li H, Xiao X,
Zhao J and Fang L: miR-497 induces apoptosis of breast cancer cells
by targeting Bcl-w. Exp Ther Med. 3:475–480. 2012.PubMed/NCBI
|
23
|
Guo ST, Jiang CC, Wang GP, Li YP, Wang CY,
Guo XY, Yang RH, Feng Y, Wang FH, Tseng HY, et al: MicroRNA-497
targets insulin-like growth factor 1 receptor and has a tumour
suppressive role in human colorectal cancer. Oncogene.
32:1910–1920. 2013. View Article : Google Scholar :
|
24
|
Flavin RJ, Smyth PC, Laios A, O'Toole SA,
Barrett C, Finn SP, Russell S, Ring M, Denning KM, Li J, et al:
Potentially important microRNA cluster on chromosome 17p13.1 in
primary peritoneal carcinoma. Mod Pathol. 22:197–205. 2009.
View Article : Google Scholar
|
25
|
Zhao X, Zhao Z, Xu W, Hou J and Du X:
Down-regulation of miR-497 is associated with poor prognosis in
renal cancer. Int J Clin Exp Pathol. 8:758–764. 2015.PubMed/NCBI
|
26
|
Chang S, Gao L, Yang Y, Tong D, Guo B, Liu
L, Li Z, Song T and Huang C: miR-145 mediates the antiproliferative
and gene regulatory effects of vitamin D3 by directly targeting
E2F3 in gastric cancer cells. Oncotarget. 6:7675–7685. 2015.
View Article : Google Scholar : PubMed/NCBI
|
27
|
Kanai D, Ueda A, Akagi T, Yokota T and
Koide H: Oct3/4 directly regulates expression of E2F3a in mouse
embryonic stem cells. Biochem Biophys Res Commun. 459:374–378.
2015. View Article : Google Scholar : PubMed/NCBI
|
28
|
Chen PH, Shih CM, Chang WC, Cheng CH, Lin
CW, Ho KH, Su PC and Chen KC: MicroRNA-302b-inhibited E2F3
transcription factor is related to all trans retinoic acid-induced
glioma cell apoptosis. J Neurochem. 131:731–742. 2014. View Article : Google Scholar : PubMed/NCBI
|
29
|
An Q, Wang Y, An R, Li Y, Yao T, Zhai B
and Sun X: Association of E2F3 expression with clinicopathological
features of Wilms' tumors. J Pediatr Surg. 48:2187–2193. 2013.
View Article : Google Scholar : PubMed/NCBI
|
30
|
Cooper CS, Nicholson AG, Foster C, Dodson
A, Edwards S, Fletcher A, Roe T, Clark J, Joshi A, Norman A, et al:
Nuclear overexpression of the E2F3 transcription factor in human
lung cancer. Lung Cancer. 54:155–162. 2006. View Article : Google Scholar : PubMed/NCBI
|
31
|
Tao T, Liu D, Liu C, Xu B, Chen S, Yin Y,
Ang L, Huang Y, Zhang X and Chen M: Autoregulatory feedback loop of
EZH2/miR-200c/E2F3 as a driving force for prostate cancer
development. Biochim Biophys Acta. 1839:858–865. 2014. View Article : Google Scholar : PubMed/NCBI
|
32
|
Song C, Wu G, Xiang A, Zhang Q, Li W, Yang
G, Shi X, Sun S and Li X: Over-expression of miR-125a-5p inhibits
proliferation in C2C12 myoblasts by targeting E2F3. Acta Biochim
Biophys Sin. 47:244–249. 2015. View Article : Google Scholar : PubMed/NCBI
|
33
|
Xue J, Niu YF, Huang J, Peng G, Wang LX,
Yang YH and Li YQ: miR-141 suppresses the growth and metastasis of
HCC cells by targeting E2F3. Tumour Biol. 35:12103–12107. 2014.
View Article : Google Scholar : PubMed/NCBI
|
34
|
Lee JM, Heo MJ, Lee CG, Yang YM and Kim
SG: Increase of miR-199a-5p by protoporphyrin IX, a photocatalyzer,
directly inhibits E2F3, sensitizing mesenchymal tumor cells to
anticancer agents. Oncotarget. 6:3918–3931. 2015. View Article : Google Scholar : PubMed/NCBI
|